Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 28,391

Document Document Title
WO/2013/027694A1
The purpose of the present invention is to provide a near infrared light-emitting compound which has an ability to highly specifically binding to Aβ, a high permeability through the blood-brain barrier, an ability to quickly disappear f...  
WO/2013/026724A1
The present invention relates to compounds of formula (IA) wherein QA is QA1 or QA2 P is P1, heterocyclyl or heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Z, R1, R2, R3 and R4 are as defined in claim 1; or a ...  
WO/2013/028289A1
Described herein are oxygen scavengers, oxygen scavenging polymeric compositions, and oxygen scavenging articles. The polymeric compositions comprising the oxygen scavengers may have utility in packaging, sealing, wrapping, and storing o...  
WO/2013/026737A3
The invention relates to a method for producing γ-hydroxycarboxylic esters and γ-lactones, which are suitable as aromatic substances, by electrochemical reductive cross-coupling of α,β-unsaturated esters with carbonyl compounds in an...  
WO/2013/025564A2
Furfural is produced from a xylan-containing lignocellulosic feedstock which is contacted with water in the presence of an acid catalyst. Specifically, the catalyst is sulfuric acid characterized by a room temperature pH in the range of ...  
WO/2013/024730A1
This organic electroluminescent element, which uses a compound represented by the belowmentioned general formula, emits dark blue light and has a low change in chromaticity and a low change in driving voltage after long-term driving. (R1...  
WO/2013/024162A1
This invention relates to an efficient procedure for purifying HMF by crystallization at low temperature from an organic solvent.  
WO/2013/024898A1
The primary purpose of the present invention is to provide a novel heterocyclic derivative or a pharmaceutically acceptable salt thereof. Examples of the present invention can include a heterocyclic compound represented by general formul...  
WO/2013/025733A1
Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one ...  
WO/2013/024493A8
This invention relates to diterpenes of general formula (1) belonging to labdane class, isolated from Leucas stelligera, being useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity...  
WO/2013/025564A3
Furfural is produced from a xylan-containing lignocellulosic feedstock which is contacted with water in the presence of an acid catalyst. Specifically, the catalyst is sulfuric acid characterized by a room temperature pH in the range of ...  
WO/2013/024493A1
This invention relates to diterpenes of general formula (1) belonging to labdane class, isolated from Leucas stelligera, being useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity...  
WO/2013/026024A1
An energy curable bonding resin composition that prevents corrosion in metallic optical structures including DVDs includes at least one monomer, acrylated epoxidized soya bean oil, and a photoinitiator of among 2,4,6-trimethylbenzoyl-dip...  
WO/2013/023140A8
Post purification processes and methods for making pure biobased gamma-butyrolactone from renewable carbon resources comprising filtration and/or distillation and/or peroxide treatment are described herein.  
WO/2013/021971A1
[Problem] To provide an organic photoelectric conversion element whereby conversion efficiency is increased by morphology reformation in a power generation layer, and whereby short-circuit current (Jsc) attenuation when emitting light is...  
WO/2013/023140A1
Post purification processes and methods for making pure biobased gamma-butyrolactone from renewable carbon resources comprising filtration and/or distillation and/or peroxide treatment are described herein.  
WO/2013/020285A1
Provided are a method for preparing Antrocin through total chemical synthesis and a use of a composition containing Antrocin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier in preparing drugs for s...  
WO/2013/018105A2
A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble ...  
WO/2013/017654A1
Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estro...  
WO/2013/016193A3
The present invention provides compounds of Formulae (A), (B), (C), and (D), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof...  
WO/2013/014478A1
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof : Formula (I) characterized in that a compound of formula (II) : Formula (II) is aminated with compound ...  
WO/2013/014480A1
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof characterized in that the compound of formula (II) is reduced, and the obtained product is isolated and,...  
WO/2013/014479A1
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof, characterized in that the compound of formula (II) is reacted with dibutylamine of formula (III), under...  
WO/2013/014997A1
A novel metal salen complex compound having auto-magnetic properties, and a derivative thereof are provided. The present invention is a metal salen complex compound comprising any of the listed compounds.  
WO/2013/014204A3
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/014204A2
The present invention relates to compounds of the formula I, wherein Ht, G, R10, R30, R40, R50 and R60 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cat...  
WO/2013/016193A2
The present invention provides compounds of Formulae (A), (B), (C), and (D), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof...  
WO/2013/012590A1
Methods for forming ammonium salts of C4 diacids in a fermentation process with removal of divalent metal carbonate salts are disclosed. The pH of fermentation broths for production of C4 diacids is controlled by adding alkaline oxygen c...  
WO/2013/011893A1
Provided are: a novel (meth)acrylate compound which can yield a cured product having a high refractive index and is therefore suitable for optical materials; and a plastic lens obtained using the same. A compound which has a fluorene ske...  
WO/2013/008700A1
An actinic ray-sensitive or radiation-sensitive resin composition, includes: (A) a compound represented by the following formula (I); and (B) a resin: wherein X represents an oxygen atom, a sulfur atom or -N(Rx)-; each of R1 to R8 and Rx...  
WO/2013/007832A1
The present invention relates to a process for manufacturing tetrahydrofuran, tetrahydropyran and, more generally, cycloether derivatives through the cyclodehydration of 1,4- or 1,5- diols. More specifically, the process of the invention...  
WO/2013/008044A1
The current invention covers the synthesis of (+) and (-) l-(5,5-diphenyItetrahydrofuran-3- yl)-N,N-dimethylmethanamine [(±)1] and [(-)1] respectively, including their pharmacologically acceptable acid addition salts. The new products c...  
WO/2013/009844A2
C3-functionalized-cyclopentanyltetrahydrofuranyl carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are described. Compositions comprising the disclosed compound and methods of using the compounds a...  
WO/2013/009844A3
C3-functionalized-cyclopentanyltetrahydrofuranyl carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are described. Compositions comprising the disclosed compound and methods of using the compounds a...  
WO/2013/007586A1
The present invention relates to the production of compounds comprising nitrile functions and of cyclic imide compounds. It relates more particularly to the production of compounds comprising nitrile functions from compounds comprising c...  
WO/2013/004190A1
Disclosed are immune-modulators of formula (I), the preparation method thereof, a pharmaceutical composition containing the immune-modulators, and the use of the pharmaceutical composition as a drug, especially as an immune-modulating dr...  
WO/2013/005749A1
The present invention is a method for producing tetrahydrofuran by means of a cyclodehydration reaction of 1,4-butanediol in the presence of an acid catalyst having a pKa value of no greater than 4 in a reaction vessel, wherein a startin...  
WO/2013/006539A1
A furfuryl alcohol derivative having the general formula X [-CH(OR)2]m is prepared by an aldehyde with a furfuryl alcohol in the presence of a copper catalyst. In this formula, X is an aliphatic, cycloaliphatic, aromatic or araliphatic g...  
WO/2013/005750A1
The present invention is a method that is for producing tetrahydrofuran and that produces tetrahydrofuran by supplying a starting material 1,4-butanediol containing gamma-butyrolactone to a reaction tank and performing a cyclodehydration...  
WO/2013/000395A1
Disclosed in the present invention is a novel histone deacetylase inhibitor of benzamides and use thereof; the inhibitor has good efficacy in treating diseases caused by abnormal gene expression, such as tumours, endocrine disorders, imm...  
WO/2013/002217A1
A compound which is represented by general formula (1) (wherein R1 to R4 each independently represent a hydrogen atom, a halogen atom, a hydroxy, mercapto, nitro, or amino group, or an aromatic, alkoxy, aromatic-oxy, alkylamino, aromatic...  
WO/2013/000275A1
Disclosed are compounds as shown as general formula (I), derivatives and uses thereof, wherein R1, R2, R3, R4, R5a, R5b, R5c and X have the definition as same as the description.  
WO/2013/002397A1
The present invention is a method for producing a furfural compound, comprising carrying out a dehydration reaction of a saccharide in an aqueous solution comprising the saccharide and water in the presence of magnesium sulfate.  
WO/2013/003465A9  
WO/2013/000846A1
The invention relates to a method for producing cyclic enol ethers of formulas (I) and/or (II).  
WO/2013/001997A1
An organic light emitting element which realizes a high efficiency and long-life light emission is provided. An organic compound represented by the general formula [1] described in Claim 1 is provided. In the general formula [1], R1 to R...  
WO/2012/175439A1
The invention provides a process for the preparation of valerolactone, said process comprising reacting levulinic acid with hydrogen by using a solid Ru catalyst, characterised in that the process is carried out in the presence of at lea...  
WO/2012/175715A1
The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treat...  
WO/2012/176856A2
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...  
WO/2012/176856A3
The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl, alkoxy, halo...  

Matches 451 - 500 out of 28,391